Efficacy and Safety of Ranibizumab Monotherapy Versus Ranibizumab in Combination With Verteporfin Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy: 12-Month Outcomes in the Japanese Cohort of EVEREST II Study

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s171015
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

Visual Outcomes of Polypoidal Choroidal Vasculopathy Treated With Intravitreal Ranibizumab With or Without Photodynamic Therapy

Acta Ophthalmologica
MedicineOphthalmology
2017English

Photodynamic Therapy With Verteporfin for Polypoidal Choroidal Vasculopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2008English

Choroidal Morphology and Short-Term Outcomes of Combination Photodynamic Therapy in Polypoidal Choroidal Vasculopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2018English

Comparing Efficacy of Reduced-Fluence and Standard-Fluence Photodynamic Therapy in the Treatment of Polypoidal Choroidal Vasculopathy

BMC Ophthalmology
MedicineOphthalmology
2020English

Two-Year Outcome of Treat-And-Extend Aflibercept After Ranibizumab in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients

Clinical Ophthalmology
Ophthalmology
2018English

EVEREST Study Report 4: Fluorescein Angiography Features Predictive of Polypoidal Choroidal Vasculopathy

Clinical and Experimental Ophthalmology
MedicineOphthalmology
2019English

Efficacy of Aflibercept for Polypoidal Choroidal Vasculopathy in Caucasians

Acta Ophthalmologica
MedicineOphthalmology
2017English

Polypoidal Choroidal Vasculopathy

Ophthalmology
Ophthalmology
2018English

Polypoidal Choroidal Vasculopathy

Klinika Oczna
MedicineOphthalmology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy